A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer.
Zhang Z, Zhang Y, Liu C, Shao J, Chen Y, Zhu Y, Zhang L, Qin B, Kong Z, Wang X, Wang Y, Huang D, Liu L, Zhou Y, Tao R, Yang Z, Liu M, Zhao W.
Zhang Z, et al.
Cancer Innov. 2023 Apr 23;2(3):172-180. doi: 10.1002/cai2.70. eCollection 2023 Jun.
Cancer Innov. 2023.
PMID: 38089401
Free PMC article.